Indeed, the high upregulation of CXCR3 observed in our expanded NK cell product could be potentially relevant in this situation as well, since the levels of its ligands, CXCL9/10, have been shown to be elevated in the BM of AML patients [51]. This evidence concerns the gene CXCL9 and acute myeloid leukemia.